The FDA announced on March 29, 2019, that X-Gen Pharmaceuticals Inc. voluntarily recalled Clonidine HCL Injection due to a labeling error listing an incorrect concentration. The agency classified the Class III recall as terminated.
How to tell if you have it
- Brand: X-Gen
- Product: Clonidine HCL Injection, 1000 mcg/10mL (100 mcg/mL), 10 ML Single Dose Vial
- NDC: 39822-2000-1
- Lots: PMXA1917 (Exp 09/2020); PMXA1937, PMXA1938 (Exp 11/2020)
- Quantity: 24,966 vials
The hazard
The side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine Hydrochloride" per mL.
Context
GovInfoNow's records show X-Gen Pharmaceuticals Inc. has 6 other recalls on record since July 17, 2014. Other recent recalls include X-Gen Cyclophosphamide Injection (April 2, 2024), X-Gen Neomycin Sulfate Tablets (March 19, 2021), and X-Gen Levetiracetam Injection (Oct. 11, 2019).